Data Breach Law Group Investigates the Travere Therapeutics, Inc. Data Breach
By Data Breach Law Group | Posted on October 27, 2025 · New Hampshire
Miami, FL — Data Breach Law Group is investigating a data breach involving Travere Therapeutics, Inc., reported to the New Hampshire Attorney General on October 27, 2025. The firm is reviewing whether affected individuals have legal claims arising from the incident.
Travere Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare diseases, placing it within the healthcare and life sciences sector. Given the nature of its business, the company likely maintains sensitive patient records, clinical trial data, and health-related information, which are subject to stringent privacy protections. This data breach was officially reported to the New Hampshire Attorney General in 2025, triggering formal disclosure requirements. If you have received a data breach notification letter from the company, it indicates that your personal or protected health information may have been involved in this security incident. We recommend reviewing the letter carefully to understand the specific scope of the exposure and the identity protection services being offered to affected individuals.
If you were affected
Stay alert to targeted scams
Be cautious of calls, texts, or emails that reference this breach. Legitimate organizations won't ask you to confirm sensitive details through an unsolicited message.
Keep your notification letter
Save the notice you received. It documents that your information was involved and is often needed to enroll in any credit monitoring offered or to join a related legal claim.
Did you receive a letter from Travere Therapeutics, Inc.?
A case review is free and confidential. Tell us about your letter and we will explain your options.